nla iv enzyme  (New England Biolabs)


Bioz Verified Symbol New England Biolabs is a verified supplier
Bioz Manufacturer Symbol New England Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    New England Biolabs nla iv enzyme
    A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism <t>(RFLP)</t> analysis with <t>Nla</t> IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in
    Nla Iv Enzyme, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nla iv enzyme/product/New England Biolabs
    Average 94 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    nla iv enzyme - by Bioz Stars, 2022-10
    94/100 stars

    Images

    1) Product Images from "Pure myopathy with enlarged mitochondria associated to a new mutation in MTND2 gene"

    Article Title: Pure myopathy with enlarged mitochondria associated to a new mutation in MTND2 gene

    Journal: Molecular Genetics and Metabolism Reports

    doi: 10.1016/j.ymgmr.2016.11.009

    A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism (RFLP) analysis with Nla IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in
    Figure Legend Snippet: A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism (RFLP) analysis with Nla IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in

    Techniques Used: Amplification, Mutagenesis

    2) Product Images from "Pure myopathy with enlarged mitochondria associated to a new mutation in MTND2 gene"

    Article Title: Pure myopathy with enlarged mitochondria associated to a new mutation in MTND2 gene

    Journal: Molecular Genetics and Metabolism Reports

    doi: 10.1016/j.ymgmr.2016.11.009

    A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism (RFLP) analysis with Nla IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in
    Figure Legend Snippet: A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism (RFLP) analysis with Nla IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in

    Techniques Used: Amplification, Mutagenesis

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    New England Biolabs nla iv enzyme
    A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism <t>(RFLP)</t> analysis with <t>Nla</t> IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in
    Nla Iv Enzyme, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nla iv enzyme/product/New England Biolabs
    Average 94 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    nla iv enzyme - by Bioz Stars, 2022-10
    94/100 stars
      Buy from Supplier

    90
    New England Biolabs restriction enzymes nla iv
    A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism <t>(RFLP)</t> analysis with <t>Nla</t> IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in
    Restriction Enzymes Nla Iv, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/restriction enzymes nla iv/product/New England Biolabs
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    restriction enzymes nla iv - by Bioz Stars, 2022-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism (RFLP) analysis with Nla IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in

    Journal: Molecular Genetics and Metabolism Reports

    Article Title: Pure myopathy with enlarged mitochondria associated to a new mutation in MTND2 gene

    doi: 10.1016/j.ymgmr.2016.11.009

    Figure Lengend Snippet: A: Multi-alignment analysis. The comparison of the aminoacid sequences around Gly-121 in ND2 protein using clustalW between different species shows the high conservation of residue. B: Strategy of restriction fragment length polymorphism (RFLP) analysis with Nla IV enzyme. In the wt mtDNA molecules the Nla IV enzyme cut the 360 bp amplified fragment in two smaller fragment (192 bp and 168 bp), the mutation m.4831G > A abolishes the restriction site resulting the uncutted band. C: Result of RFLP analysis in patient and his family. The mutation is present in 95% of mtDNA from patient's muscle tissue (M), in 40% of genomes from urinary sediment (U), in

    Article Snippet: PCR-RFLP analysis performed to quantify the mutation in different tissues using the Nla IV enzyme ( B) showed the presence of the m.4831G > A change in the 95% of mitochondrial genomes from patient's muscle, in the 40% of genomes from urinary tract cells and only in < 5% of genomes from patient's peripheral blood lymphocytes.

    Techniques: Amplification, Mutagenesis